BiFlow Medical

Company Overview

Snapshot

Founded in December 2010 by Oren Shuster and Haim Ackerman, BiFlow Medical operates with 1–10 employees. The company has secured funding across two rounds from four investors, with its most recent funding round in July 2019.

Business overview

BiFlow Medical develops minimally invasive therapies for abdominal aortic aneurysm (AAA), focusing on a mechanism that integrates two unique stents: a side-branch stent and an extension graft stent. This technology aims to enable blood flow through the renal artery, increasing the number of patients eligible for endovascular aneurysm repair (EVAR) and ultimately seeking to replace traditional AAA surgeries with EVAR. The company operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics, targeting healthcare providers.

Company Intelligence Q&A

What is BiFlow Medical's core product?

BiFlow Medical has developed a minimally invasive therapy for abdominal aortic aneurysm (AAA) that integrates a side-branch stent and an extension graft stent. This mechanism is designed to facilitate blood flow through the renal artery, expanding the applicability of endovascular aneurysm repair (EVAR).

When was BiFlow Medical founded?

BiFlow Medical was founded in December 2010.

Who are the founders of BiFlow Medical?

BiFlow Medical was co-founded by Oren Shuster and Haim Ackerman.

When did BiFlow Medical last raise funding?

BiFlow Medical secured its most recent funding round in July 2019, with investments from Shizim Group and Gary Jacobs.

Which investors participated in BiFlow Medical's September 2014 funding round?

In September 2014, BiFlow Medical received funding from NGT3 and Varda Leshem.